Literature DB >> 1678110

Chimaeric anti-CD4 monoclonal antibody for relapsing polychondritis.

E H Choy, I C Chikanza, G H Kingsley, G S Panayi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1678110     DOI： 10.1016/0140-6736(91)91076-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Relapsing polychondritis: a review.

Authors:  Aman Sharma; Karthik Gnanapandithan; Kusum Sharma; Susmita Sharma
Journal:  Clin Rheumatol       Date:  2013-07-26       Impact factor: 2.980

2.  In vivo treatment with a monoclonal chimeric anti-CD4 antibody results in prolonged depletion of circulating CD4+ cells in chimpanzees.

Authors:  M Jonker; W Slingerland; G Treacy; P van Eerd; K Y Pak; E Wilson; S Tam; K Bakker; A F Lobuglio; P Rieber
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

3.  Critical airway involvement in relapsing polychondritis.

Authors:  Camilla Gorard; Saleheen Kadri
Journal:  BMJ Case Rep       Date:  2014-09-11

4.  A nationwide study of the epidemiology of relapsing polychondritis.

Authors:  Anna Horváth; Nóra Páll; Katalin Molnár; Tamás Kováts; György Surján; Tamás Vicsek; Péter Pollner
Journal:  Clin Epidemiol       Date:  2016-06-23       Impact factor: 4.790

Review 5.  Refractory relapsing polychondritis: challenges and solutions.

Authors:  Fernando Kemta Lekpa; Xavier Chevalier
Journal:  Open Access Rheumatol       Date:  2018-01-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.